Sergey Terushkin, MD, FACS About GoalBMI Wellness GoalBMI Wellness provides physician-guided telehealth weight loss and wellness services for eligible patients throughout New York
GLP-1 Treatments, Semaglutide or Tirzepatide is a medication developed to help individuals struggling with obesity manage their weight more effectively
Injection Site Reactions Mild redness or discomfort at injection site
Pricing, policy terms, and program details are subject to change
A BMI of 27 or higher (overweight) qualifies if you also have one or more weight-related conditions, such as: Hypertension, which increases cardiovascular risk Type 2 diabetes, which has been closely linked to excess weight High cholesterol, which is known to raise the risk of heart disease Sleep apnea, often worsened by obesity Cardiovascular disease, such as a previous history of heart attack or stroke Step therapy rules Step therapy is a cost-control rule used by many insurers